Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis

Published:2022-10-25 Issue:1 Volume:30 Page:187-194
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Camara‐Lemarroy Carlos¹²³^ORCID,Silva Claudia¹²,Gohill Jit⁴,Yong V. Wee¹²,Koch Marcus¹²⁵^ORCID

Affiliation:

1. Department of Clinical Neurosciences University of Calgary Calgary Alberta Canada

2. Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada

3. UANL School of Medicine Monterrey Mexico

4. Section of Ophthalmology, Department of Surgery University of Calgary Calgary Alberta Canada

5. Department of Community Health Sciences University of Calgary Calgary Alberta Canada

Funder

Government of Alberta

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15588

Reference35 articles.

1. Primary-progressive multiple sclerosis

2. Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

3. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

4. Hydroxychloroquine for Primary Progressive Multiple Sclerosis

5. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Selected Parameters of Brain Injury Reflect Neuronal Damage in Smoldering Multiple Sclerosis?;Diagnostics;2024-09-09

2. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation;Journal of the Neurological Sciences;2024-06

3. Biomarkers of disability worsening in inactive primary progressive multiple sclerosis;Journal of Neuroimmunology;2024-02

4. From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment;Biomedicines;2023-11-16

5. Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis;Frontiers in Neurology;2023-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3